| Drug Name | Janus kinase inhibitors |
|---|---|
| المجموعة الدوائية | |
| نوع وسيلة تقليل المخاطر |
رسالة سلامة دوائية
|
| Specialty (Theraputic area) | |
| المخاطر |
Minimize the risks of serious side effects (cardiovascularevents, blood clots, cancer, serious infections and mortality) |
| safety communication |
|